Newbridge Financial Services Group’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.81K Hold
1,352
﹤0.01% 1035
2025
Q4
$3.31K Hold
1,352
﹤0.01% 963
2025
Q3
$9.07K Hold
1,352
﹤0.01% 917
2025
Q2
$7.95K Hold
1,352
﹤0.01% 943
2025
Q1
$11.3K Hold
1,352
﹤0.01% 655
2024
Q4
$10.1K Hold
1,352
﹤0.01% 737
2024
Q3
$7.84K Sell
1,352
-5,421
-80% -$34.8K ﹤0.01% 458
2024
Q2
$45K Hold
6,773
0.02% 396
2024
Q1
$88.4K Sell
6,773
-350
-5% -$4.67K 0.04% 308
2023
Q4
$90.8K Buy
7,123
+3,567
+100% +$36K 0.04% 289
2023
Q3
$46.6K Buy
3,556
+733
+26% +$13.4K 0.02% 425
2023
Q2
$72.2K Hold
2,823
0.04% 374
2023
Q1
$71.1K Buy
2,823
+369
+15% +$8.66K 0.04% 384
2022
Q4
$56.4K Hold
2,454
0.03% 427
2022
Q3
$54K Buy
2,454
+547
+29% +$10.6K 0.03% 436
2022
Q2
$27K Hold
1,907
0.02% 566
2022
Q1
$36K Sell
1,907
-318
-14% -$6.18K 0.02% 562
2021
Q4
$41K Hold
2,225
0.02% 521
2021
Q3
$60K Buy
2,225
+907
+69% +$25K 0.04% 365
2021
Q2
$41K Buy
+1,318
New +$42K 0.03% 509

Other funds holding TMCI